Tema Cardiovascular and Metabolics ETF Rating $27.69 +0.28 (+1.02%) As of 04/17/2025 03:30 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Cardiovascular and Metabolics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.81Holdings in HRTS have an aggregate rating of Moderate Buy based on 631 analyst ratings issued in the past year covering 38 companies (84.0% of the portfolio).HRTS Aggregate Price Target$27.69High Prediction$27.69Average Prediction$27.69Low Prediction$27.69Holdings in HRTS have an aggregate price target of $27.69 and a range of $27.69 to $27.69 covering 38 companies (84.0% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Cardiovascular and Metabolics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.94%LLYEli Lilly and Company$841.70+14.5%4.8313 of 5 stars2.89$1,012.00 20.2%19News CoverageGap UpHigh Trading Volume7.17%UNHUnitedHealth Group$456.10-22.0%4.7261 of 5 stars3.13$632.85 38.8%23Earnings ReportAnalyst UpgradeNews CoverageGap DownHigh Trading Volume4.03%BBIOBridgeBio Pharma$33.87+0.1%4.5979 of 5 stars2.92$53.00 56.5%12Analyst ForecastInsider TradeAnalyst RevisionNews Coverage4.01%ABTAbbott Laboratories$131.00+1.0%4.8652 of 5 stars2.84$142.59 8.8%19Earnings ReportEx-DividendAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage3.74%RHHBYRoche$38.90+0.8%N/A2.5063.65%VRTXVertex Pharmaceuticals$489.10+0.7%4.107 of 5 stars2.64$512.41 4.8%25Short Interest ↓Positive News3.20%GILDGilead Sciences$104.49-0.4%4.5367 of 5 stars2.72$105.12 0.6%29Upcoming EarningsInsider TradePositive News3.10%MDTMedtronic$82.58-0.1%4.6764 of 5 stars2.44$96.14 16.4%16Short Interest ↓Positive News3.06%BSXBoston Scientific$95.08-0.2%4.4314 of 5 stars3.04$110.22 15.9%23Upcoming EarningsAnalyst UpgradeNews CoveragePositive News2.87%TMOThermo Fisher Scientific$426.11-2.4%4.9272 of 5 stars2.81$642.67 50.8%21Upcoming EarningsAnalyst ForecastNews CoveragePositive News2.65%MRKMerck & Co., Inc.$77.93+1.9%4.9993 of 5 stars2.64$115.50 48.2%22Upcoming EarningsAnalyst Forecast2.53%BMYBristol-Myers Squibb$49.24-0.3%4.7334 of 5 stars2.32$57.67 17.1%19Upcoming EarningsShort Interest ↓Analyst RevisionNews CoveragePositive News2.46%CRNXCrinetics Pharmaceuticals$30.42+2.8%3.6046 of 5 stars2.92$73.00 140.0%13Positive News2.27%ABBVAbbVie$172.78+0.6%4.9013 of 5 stars2.85$210.71 22.0%26Upcoming EarningsEx-DividendAnalyst ForecastAnalyst RevisionPositive News2.09%CYTKCytokinetics$39.48+0.8%3.7597 of 5 stars2.94$81.63 106.8%18Analyst ForecastInsider TradeNews Coverage2.06%EWEdwards Lifesciences$71.56+0.5%4.1235 of 5 stars2.38$78.55 9.8%24Upcoming EarningsAnalyst RevisionNews CoveragePositive News1.99%REGNRegeneron Pharmaceuticals$563.16+2.5%4.876 of 5 stars2.77$963.56 71.1%26Analyst ForecastNews CoveragePositive News1.93%DHRDanaher$186.71-2.1%4.938 of 5 stars2.85$274.55 47.0%20Upcoming EarningsAnalyst ForecastShort Interest ↓Positive NewsGap Up1.92%MCKMcKesson$697.22+0.4%4.5747 of 5 stars2.88$668.50 -4.1%16Positive News1.90%PODDInsulet$246.80-1.6%4.5817 of 5 stars2.82$292.06 18.3%17Short Interest ↓Positive NewsGap Down1.87%ALNYAlnylam Pharmaceuticals$234.56+1.8%4.6213 of 5 stars2.77$315.58 34.5%26Analyst Revision1.86%AMGNAmgen$277.29-1.9%4.6072 of 5 stars2.48$314.91 13.6%23Analyst DowngradeAnalyst Revision1.56%ASNDAscendis Pharma A/S$165.05+4.4%2.2766 of 5 stars2.93$204.67 24.0%15Analyst ForecastNews Coverage1.47%DXCMDexCom$68.59-0.2%4.9049 of 5 stars2.95$99.00 44.3%20Positive NewsGap Down1.28%MREOMereo BioPharma Group$2.30+8.0%2.0556 of 5 stars3.25$7.71 235.4%8High Trading Volume1.28%MDGLMadrigal Pharmaceuticals$301.66-2.0%4.4451 of 5 stars2.80$378.44 25.5%10News CoveragePositive NewsGap Up1.22%MASIMasimo$152.15+0.3%4.4227 of 5 stars2.83$194.80 28.0%6News CoveragePositive News1.11%INSMInsmed$72.53+3.3%4.1733 of 5 stars3.00$94.00 29.6%16Insider TradeNews CoveragePositive News0.83%MIRMMirum Pharmaceuticals$39.10+0.9%3.9585 of 5 stars3.09$58.20 48.8%11Analyst RevisionNews CoveragePositive News0.80%WSTWest Pharmaceutical Services$201.78-3.5%4.631 of 5 stars2.86$332.50 64.8%7Upcoming EarningsHigh Trading Volume0.80%IONSIonis Pharmaceuticals$28.40+0.2%4.0408 of 5 stars2.70$56.72 99.7%20Analyst ForecastAnalyst Revision0.74%AKROAkero Therapeutics$37.63+0.5%4.2728 of 5 stars3.00$76.29 102.7%9Insider TradePositive NewsGap Up0.71%VKTXViking Therapeutics$23.94+1.4%4.3556 of 5 stars2.92$89.75 274.9%13Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageGap Down0.59%GPCRStructure Therapeutics$21.76+17.4%2.5883 of 5 stars3.00$81.29 273.6%8News CoverageGap UpHigh Trading Volume0.55%ARWRArrowhead Pharmaceuticals$11.24-1.0%3.539 of 5 stars2.60$41.44 268.7%10News Coverage0.33%RCKTRocket Pharmaceuticals$6.33+2.9%4.6277 of 5 stars2.92$43.00 579.3%12News CoveragePositive News0.22%NTLAIntellia Therapeutics$7.23+5.4%4.4054 of 5 stars2.63$37.56 419.4%19Gap Up0.16%MTSRMetsera$19.57+11.5%N/A3.00$47.00 140.2%4 This page (NASDAQ:HRTS) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
